The Department of Neurology and Neurological Sciences at Stanford University School of Medicine, together with multiple ...
On Saturday, Oct. 11, HSHS St. Elizabeth’s Hospital will host a free educational seminar to raise awareness of the benefit ...
Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in ...
Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating.
Personalized, at-home, adaptive deep brain stimulation is safe and effective for patients with moderate-to-advanced Parkinson ...
Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback